About Us‎ > ‎Latest News‎ > ‎

New Drugs for relapsing remitting MS

posted 25 Feb 2014, 05:10 by Alan B.
There is a lot happening in the world of pharmaceuticals and it is hard to keep up to date. This website steers clear of diagnosis and treatment of MS but we like to keep up with the news especially as it relates to MSers in Moray. There have been some important decisions made recently that affect availability of MS drug therapies:

Teriflunomide (Aubagio) has been approved by NICE in England and Wales and a decision is pending by the Scottish Medicines Consortium.

Alemtuzumab (Lemtrada) has been turned down by NICE though they will review again.

Dimethyl fumerate (BG-12, Tecfidera) has recently been licensed by Europe but not yet in the UK.

Laquinimod (Nerventra) has been turned down by Europe.

The excellent MS Trust have a booklet on Disease modifying drugs and their website gives the latest news. Have a look HERE.

The MS Society Campaign team in Scotland are also pressurising the Scottish Medicines Consortium to make positive and prompt decisions. Any news will also be posted here!

If you have concerns about your treatment speak to the Moray MS Specialist Nurse.